Cargando…
Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts
Plasminogen activator inhibitor‐1 (PAI‐1) promotes pulmonary fibrosis through increasing myofibroblast (MF) characteristics, expressing alpha‐smooth muscle actin (α‐SMA) in fibroblasts. Fibroblasts in the tumour stroma are called cancer‐associated fibroblasts (CAFs). Some CAFs have MF characteristic...
Autores principales: | Masuda, Takeshi, Nakashima, Taku, Namba, Masashi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Miyamoto, Shintaro, Iwamoto, Hiroshi, Fujitaka, Kazunori, Miyata, Yoshihiro, Hamada, Hironobu, Okada, Morihito, Hattori, Noboru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433668/ https://www.ncbi.nlm.nih.gov/pubmed/30734495 http://dx.doi.org/10.1111/jcmm.14205 |
Ejemplares similares
-
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
por: Tokumo, Kentaro, et al.
Publicado: (2023) -
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
por: Shimoji, Kiyofumi, et al.
Publicado: (2023) -
Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients
por: Miwata, Kei, et al.
Publicado: (2018) -
Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Ito, Noriaki, et al.
Publicado: (2021) -
Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
por: Horimasu, Yasushi, et al.
Publicado: (2021)